5 Top Losers In Healthcare Sector (LIFE, SENS, GHSI…)

pharmadown july18

The following are some of the pharma/biotech stocks that posted the biggest percentage decline on Thursday.

1. aTyr Pharma Inc. (LIFE)

Lost 22.49% to close Thursday's (July 18) trading at $4.17.

News: The Company hosted a Key Opinion Leader (KOL) call and webcast on pulmonary sarcoidosis and the current treatment landscape on July 18.

Clinical Trials & Near-term Catalyst:

The Company's lead program is ATYR1923, which is currently being evaluated in a Phase 1b/2a study in patients with pulmonary sarcoidosis.

Interim data from the trial is expected in 4Q 2019, with study completion slated in mid-2020.

2. Senseonics Holdings Inc. (SENS)

Senseonics Holdings is a revenue-generating medical technology company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes.

Lost 14.73% to close Thursday's trading at $1.10.

News: The Company has priced a registered underwritten public offering of 22.72 million shares of its common stock at a price to the public of $1.10 per share.

The offering is expected to close on July 22, 2019.

Near-term Catalyst:

The Company is slated to report second-quarter 2019 financial results in the first week of August.

Preliminary net revenue for the second quarter of 2019 is expected to be in the range of $4.4 million to $4.7 million compared to $3.6 million in the second quarter of 2018. Revenue in the first quarter of 2019 was $3.4 million.

3. NovaBay Pharmaceuticals Inc. (NBY)

NovaBay is a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market.

Lost 14.29% to close Thursday's trading at $1.08.

News: No news

Recent event:

On May 21, 2019, the Company was notified that it is not in compliance with Sections 1003(a)(i) and 1003(a)(ii) of the NYSE American Company Guide requiring stockholders' equity of $2.0 million or more and $4.0 million or more, respectively, if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. The Company has time until October 12, 2020, to regain compliance.

4. Guardion Health Sciences Inc. (GHSI)

Guardion Health is an ocular health sciences and technologies company.

Lost 12.90% to close Thursday's trading at $1.62.

News: No news

Recent event:

The Company went public on the Nasdaq Capital Market on April 5, 2019, offering its shares at a price $4.00 each.


The Company markets a medical food product under the brand name Lumega-Z that replenishes and restores the macular protective pigment in conditions such as age-related macular degeneration ("AMD"), computer vision syndrome ("CVS") and diabetic retinopathy. In June of this year, the Company launched its second ocular health formula, GlaucoCetin for glaucoma.

Another product in the kitty is a proprietary medical device called the MapcatSF that accurately measures the macular pigment optical density. The device is currently classified by the FDA as a Class I medical device which does not require pre-market approval.

5. Dynatronics Corporation (DYNT)

Dynatronics is a medical device company.

Lost 12.79% to close Thursday's trading at $1.50.

News: No news

Recent event:

On May 14, 2019, the Company reported financial results for its third fiscal quarter ended March 31, 2019.

Net loss for the quarter ended March 31, 2019 narrowed to $563,000 or $0.09 per share from $1.3 million or $0.18 per share in the year-ago quarter. Net sales for the recent third fiscal quarter were $14.6 million, a decrease of $2.0 million, or 12.5 percent, compared to $16.6 million in the same period of the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT